Popovits Kimberly J

DirectorTalis Biomedical Corp (TLIS) · full profile →Form 4 · filed Feb 19, 2021
Net Buying
Open-Market Buys
$85K
Open-Market Sells
$0
Net Open-Market Flow
$85K
Transactions
9
5 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 17, 2021Conversion(C)92K92K
Feb 17, 2021Buy(P)5K$16.00$85K215K
Feb 17, 2021Conversion(C)210K210K
Feb 17, 2021Conversion(C)90K182K
Feb 17, 2021Conversion(C)22K26K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 17, 2021Conversion(C)32K$00
Feb 17, 2021Conversion(C)129K$00
Feb 17, 2021Conversion(C)132K$00
Feb 17, 2021Conversion(C)300K$00

Transaction Codes

C
Conversion of a derivative
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-21-012522) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.